Literature DB >> 12933465

Percutaneous radiofrequency ablation of pulmonary malignancies: combined treatment with brachytherapy.

Sapna K Jain1, Damian E Dupuy, Gene A Cardarelli, Zhen Zheng, Thomas A DiPetrillo.   

Abstract

OBJECTIVE: The purpose of this article is to report the clinical experience and technical feasibility of percutaneous radiofrequency ablation in conjunction with brachytherapy, a novel approach in the treatment of lung neoplasms. Data from three patients with lung malignancies illustrate the expanding therapeutic indications of this minimally invasive intervention.
CONCLUSION: Percutaneous radiofrequency ablation in conjunction with brachytherapy is a promising minimally invasive combination modality. It may be a treatment option for patients with primary, recurrent, or metastatic malignancies of the lung that are not amenable to surgery or further external beam radiation therapy.

Entities:  

Mesh:

Year:  2003        PMID: 12933465     DOI: 10.2214/ajr.181.3.1810711

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  13 in total

Review 1.  Principles of and advances in percutaneous ablation.

Authors:  Muneeb Ahmed; Christopher L Brace; Fred T Lee; S Nahum Goldberg
Journal:  Radiology       Date:  2011-02       Impact factor: 11.105

Review 2.  The role and limitations of radiofrequency ablation in treatment of bone and soft tissue tumors.

Authors:  Kamran Ahrar
Journal:  Curr Oncol Rep       Date:  2004-07       Impact factor: 5.075

3.  Current status of thermal ablation treatments for lung malignancies.

Authors:  Damian E Dupuy; Maria Shulman
Journal:  Semin Intervent Radiol       Date:  2010-09       Impact factor: 1.513

Review 4.  Interventional oncology in multidisciplinary cancer treatment in the 21(st) century.

Authors:  Andreas Adam; Lizbeth M Kenny
Journal:  Nat Rev Clin Oncol       Date:  2014-12-02       Impact factor: 66.675

Review 5.  Percutaneous image-guided cryoablation: current applications and results in the oncologic field.

Authors:  Roberto Luigi Cazzato; Julien Garnon; Nitin Ramamurthy; Guillaume Koch; Georgia Tsoumakidou; Jean Caudrelier; Francesco Arrigoni; Luigi Zugaro; Antonio Barile; Carlo Masciocchi; Afshin Gangi
Journal:  Med Oncol       Date:  2016-11-11       Impact factor: 3.064

6.  HDR-192Ir intraluminal brachytherapy in treatment of malignant obstructive jaundice.

Authors:  Yi Chen; Xiao-Lin Wang; Zhi-Ping Yan; Jie-Min Cheng; Jian-Hua Wang; Gao-Quan Gong; Sheng Qian; Jian-Jun Luo; Qing-Xin Liu
Journal:  World J Gastroenterol       Date:  2004-12-01       Impact factor: 5.742

Review 7.  Lung cancer ablation: technologies and techniques.

Authors:  Erica S Alexander; Damian E Dupuy
Journal:  Semin Intervent Radiol       Date:  2013-06       Impact factor: 1.513

8.  Tumour characteristics and therapeutic results after percutaneous radiofrequency ablation of secondary lung neoplasms.

Authors:  Didier Dequanter; Philippe Lothaire
Journal:  Clin Transl Oncol       Date:  2009-06       Impact factor: 3.405

Review 9.  Radiofrequency thermocoagulation of lung tumours. Where we are, where we are headed.

Authors:  F M Gómez; J Palussière; E Santos; T Tourdias; F Cornélis; V Sáiz; H Montes; O Eker
Journal:  Clin Transl Oncol       Date:  2009-01       Impact factor: 3.405

Review 10.  [Combined therapies including interventional radiology].

Authors:  S Clasen; P L Pereira
Journal:  Radiologe       Date:  2007-12       Impact factor: 0.803

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.